IPBC biocide extension 2026: what changes for wood treatment manufacturers

Key data

Manufacturers and distributors of biocides with IPBC for wood protection in the EU can continue marketing their products without interruption. Commission Implementing Decision (EU) 2026/1129, adopted by the European Commission on 22 May 2026, delays the expiration date of the approval of IPBC (3-iodo-2-propynyl butylcarbamate) as an active substance in biocides of product type 8, intended for wood protection.

This extension is not an exceptional novelty: the Regulation (EU) 528/2012 on biocidal products expressly provides for the possibility of postponing expiration dates when renewal or evaluation processes for an active substance are underway. What is relevant for companies is that the legal continuity of their products is guaranteed during that period.

What does this regulation establish?

The decision formally delays the date on which the approval of IPBC as an active substance in type 8 biocides would expire. Without this extension, products containing IPBC for wood protection would have lost their legal coverage in the European market upon reaching the previous expiration date.

The key points of what the regulation establishes are:

• The approval of IPBC as an active substance in biocides of product type 8 (wood protection) does not expire on the originally scheduled date.
• The extension is granted because the renewal or evaluation process for the substance is still underway.
• The legal basis is Regulation (EU) No 528/2012, which allows for this type of postponement.
• Manufacturers and distributors may continue legally marketing their products during the extension period.
• Companies must verify that their national product authorizations remain valid, as the extension affects the European approval of the substance, not automatically each national authorization.

Economic and operational impact

The direct impact of this decision is positive for companies in the sector: it eliminates the risk of having to withdraw products from the market abruptly due to expiration of the active substance approval.

Without the extension, the consequences would have been:

• Mandatory withdrawal of products containing IPBC from the European market upon expiration.
• Halt of sales and distribution until obtaining new approval.
• Possible significant economic losses for manufacturers and distributors.
• Need to reformulate products or seek alternative active substances in very short timeframes.

With the extension in force, companies maintain their normal operations. However, the operational impact is not zero: companies must review their national product authorizations to confirm that they also remain valid, as the European extension of the substance does not automatically guarantee the validity of each national authorization.

Who does it affect?

This decision directly affects the following business and professional profiles:

• Biocide manufacturers that contain IPBC (3-iodo-2-propynyl butylcarbamate) for use in wood protection.
• Distributors and marketers of biocidal products of product type 8 in the European market.
• Chemical sector companies that produce or formulate wood treatments with this active substance.
• Wood treatment manufacturers (varnishes, impregnants, protectors) that include IPBC in their formulation.
• Construction and carpentry industry that uses these products in their processes or recommends them to their customers.
• Regulatory compliance and regulatory affairs managers in chemical and construction materials companies.

Practical example

A Spanish manufacturer of wood impregnants has several products in its catalog formulated with IPBC as an active substance, authorized as type 8 biocides in Spain and other EU countries.

Without Commission Implementing Decision (EU) 2026/1129, upon reaching the expiration date of the European approval of IPBC, this manufacturer would have had to withdraw those products from the market, interrupt their marketing, and face the reformulation process or wait for new approval, with the economic and operational cost that entails.

Thanks to the extension, the manufacturer can continue marketing its products normally. However, its Regulatory Affairs manager must do two concrete things: verify that the national authorizations of each product in each country where it operates remain valid, and record in its compliance calendar the new expiration date of IPBC approval to anticipate the next renewal.

What should companies do now?

1. Confirm the legal continuity of products: Verify that products with IPBC for wood protection continue to be covered by the extension established in Commission Implementing Decision (EU) 2026/1129.
2. Review national product authorizations: The European extension of the active substance does not automatically guarantee the validity of each national authorization. Check the status of authorizations in each EU country where products are marketed.
3. Update the regulatory compliance calendar: Record the new expiration date of IPBC approval and establish internal alerts to anticipate the next renewal with sufficient notice.
4. Inform sales and distribution teams: Confirm to commercial teams and distributors that products can continue to be marketed without interruption, avoiding erroneous decisions to withdraw or halt orders.
5. Monitor the IPBC approval renewal process: Monitor publications from the ECHA (European Chemicals Agency) and the EU Official Journal to learn the outcome of the ongoing evaluation process and act in advance if the final renewal introduces new conditions.